Advisory Commission on Childhood Vaccines; Notice of Meeting, 27651 [2011-11648]

Download as PDF Federal Register / Vol. 76, No. 92 / Thursday, May 12, 2011 / Notices who do not file an advance request for a presentation, but desire to make an oral statement, may announce it at the time of the public comment period. Public participation and ability to comment will be limited to space and time as it permits. For Further Information Contact: Anyone requiring information regarding the ACCV should contact Annie Herzog, DVIC, HSB, HRSA, Room 11C–26, 5600 Fishers Lane, Rockville, MD 20857; telephone (301) 443– 6593 or e-mail: aherzog@hrsa.gov. Dated: May 5, 2011. Mary K. Wakefield, Administrator. [FR Doc. 2011–11649 Filed 5–11–11; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Commission on Childhood Vaccines; Notice of Meeting wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Advisory Commission on Childhood Vaccines (ACCV). Date and Time: June 9, 2011, 1 p.m. to 5 p.m. EDT; June 10, 2011, 9 a.m. to 12 p.m. EDT. Place: Parklawn Building (and via audio conference call), Conference Rooms G & H, 5600 Fishers Lane, Rockville, MD 20857. The ACCV will meet on Thursday, June 9 from 1 p.m. to 5 p.m. (EDT) and on Friday, June 10 from 9 a.m. to 12 p.m. (EDT). The public can join the meeting via audio conference call by dialing 1–800–369–3104 on June 9 and 10 and providing the following information: Leader’s Name: Dr. Geoffrey Evans. Password: ACCV. Agenda: The agenda items for the June meeting will include, but are not limited to: updates from the Division of Vaccine Injury Compensation (DVIC), Department of Justice (DOJ), National Vaccine Program Office, Immunization Safety Office (Centers for Disease Control and Prevention), National Institute of Allergy and Infectious Diseases (National Institutes of Health), and Center for Biologics, Evaluation and Research (Food and Drug Administration). A draft agenda and additional meeting materials will be posted on the ACCV Web site (http:// www.hrsa.gov/vaccinecompensation/ accv.htm) prior to the meeting. Agenda items are subject to change as priorities dictate. Public Comment: Persons interested in attending the meeting in person or providing an oral presentation should submit a written request, along with a copy of their presentation to: Annie Herzog, DVIC, Healthcare Systems Bureau (HSB), Health Resources and Services Administration (HRSA), Room 11C–26, 5600 Fishers Lane, Rockville, Maryland 20857 or e-mail: aherzog@hrsa.gov. Requests should contain the name, address, telephone number, e-mail address, and any business or professional affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. DVIC will notify each presenter by e-mail, mail or telephone of their assigned presentation time. Persons VerDate Mar<15>2010 14:49 May 11, 2011 Jkt 223001 Dated: May 6, 2011. Reva Harris, Acting Director, Division of Policy and Information Coordination. [FR Doc. 2011–11648 Filed 5–11–11; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Complementary & Alternative Medicine; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel; Natural Products RFA. Date: July 21–22, 2011. Time: 5 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Martina Schmidt, PhD, Scientific Review Officer, Office of Scientific Review, National Center for Complementary & Alternative Medicine, NIH, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, 301–594–3456, schmidma@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.213, Research and Training in Complementary and Alternative Medicine, National Institutes of Health, HHS) PO 00000 Frm 00019 Fmt 4703 Sfmt 9990 27651 Dated: May 6, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–11664 Filed 5–11–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; IEARDA. Date: June 6–7, 2011. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select), 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Michele C. HindiAlexander, PhD, Scientific Review Officer, Division of Scientific Review, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, 6100 Executive Blvd., Room 5B01, Bethesda, MD 20892, 301–435–8382, hindialm@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: May 6, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–11666 Filed 5–11–11; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\12MYN1.SGM 12MYN1

Agencies

[Federal Register Volume 76, Number 92 (Thursday, May 12, 2011)]
[Notices]
[Page 27651]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-11648]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Commission on Childhood Vaccines; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:

    Name: Advisory Commission on Childhood Vaccines (ACCV).
    Date and Time: June 9, 2011, 1 p.m. to 5 p.m. EDT; June 10, 
2011, 9 a.m. to 12 p.m. EDT.
    Place: Parklawn Building (and via audio conference call), 
Conference Rooms G & H, 5600 Fishers Lane, Rockville, MD 20857.
    The ACCV will meet on Thursday, June 9 from 1 p.m. to 5 p.m. 
(EDT) and on Friday, June 10 from 9 a.m. to 12 p.m. (EDT). The 
public can join the meeting via audio conference call by dialing 1-
800-369-3104 on June 9 and 10 and providing the following 
information:
    Leader's Name: Dr. Geoffrey Evans.
    Password: ACCV.
    Agenda: The agenda items for the June meeting will include, but 
are not limited to: updates from the Division of Vaccine Injury 
Compensation (DVIC), Department of Justice (DOJ), National Vaccine 
Program Office, Immunization Safety Office (Centers for Disease 
Control and Prevention), National Institute of Allergy and 
Infectious Diseases (National Institutes of Health), and Center for 
Biologics, Evaluation and Research (Food and Drug Administration). A 
draft agenda and additional meeting materials will be posted on the 
ACCV Web site (http://www.hrsa.gov/vaccinecompensation/accv.htm) 
prior to the meeting. Agenda items are subject to change as 
priorities dictate.
    Public Comment: Persons interested in attending the meeting in 
person or providing an oral presentation should submit a written 
request, along with a copy of their presentation to: Annie Herzog, 
DVIC, Healthcare Systems Bureau (HSB), Health Resources and Services 
Administration (HRSA), Room 11C-26, 5600 Fishers Lane, Rockville, 
Maryland 20857 or e-mail: aherzog@hrsa.gov. Requests should contain 
the name, address, telephone number, e-mail address, and any 
business or professional affiliation of the person desiring to make 
an oral presentation. Groups having similar interests are requested 
to combine their comments and present them through a single 
representative. The allocation of time may be adjusted to 
accommodate the level of expressed interest. DVIC will notify each 
presenter by e-mail, mail or telephone of their assigned 
presentation time. Persons who do not file an advance request for a 
presentation, but desire to make an oral statement, may announce it 
at the time of the public comment period. Public participation and 
ability to comment will be limited to space and time as it permits.
    For Further Information Contact: Anyone requiring information 
regarding the ACCV should contact Annie Herzog, DVIC, HSB, HRSA, 
Room 11C-26, 5600 Fishers Lane, Rockville, MD 20857; telephone (301) 
443-6593 or e-mail: aherzog@hrsa.gov.

    Dated: May 6, 2011.
Reva Harris,
Acting Director, Division of Policy and Information Coordination.
[FR Doc. 2011-11648 Filed 5-11-11; 8:45 am]
BILLING CODE 4165-15-P